Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347585 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347538 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347545 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347577 (4-{[3-(4-Methoxy-2-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250600 (US10167273, Example 79 | US10544126, Example 79 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10544126 (2020) BindingDB Entry DOI: 10.7270/Q2MP55NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250600 (US10167273, Example 79 | US10544126, Example 79 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347578 (4-({3-[4-Methoxy-2-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250600 (US10167273, Example 79 | US10544126, Example 79 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The ability of a compound to block the intracellular release of calcium mediated by PK1 in RBL2H3 cells expressing human PKR1 receptors is determined... | Citation and Details BindingDB Entry DOI: 10.7270/Q2CV4NKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250600 (US10167273, Example 79 | US10544126, Example 79 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9475795 (2016) BindingDB Entry DOI: 10.7270/Q20Z727W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347571 (4-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250620 (US10167273, Example 99 | US10544126, Example 99 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250620 (US10167273, Example 99 | US10544126, Example 99 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The ability of a compound to block the intracellular release of calcium mediated by PK1 in RBL2H3 cells expressing human PKR1 receptors is determined... | Citation and Details BindingDB Entry DOI: 10.7270/Q2CV4NKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250620 (US10167273, Example 99 | US10544126, Example 99 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9475795 (2016) BindingDB Entry DOI: 10.7270/Q20Z727W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250620 (US10167273, Example 99 | US10544126, Example 99 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10544126 (2020) BindingDB Entry DOI: 10.7270/Q2MP55NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250599 (US10167273, Example 78 | US10544126, Example 78 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The ability of a compound to block the intracellular release of calcium mediated by PK1 in RBL2H3 cells expressing human PKR1 receptors is determined... | Citation and Details BindingDB Entry DOI: 10.7270/Q2CV4NKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250599 (US10167273, Example 78 | US10544126, Example 78 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347585 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250599 (US10167273, Example 78 | US10544126, Example 78 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10544126 (2020) BindingDB Entry DOI: 10.7270/Q2MP55NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347579 (4-{[3-(4-Chloro-2-ethoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347518 (3-Chloro-5-{[3-(4-chloro-2-methylphenyl)piperidin-...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250599 (US10167273, Example 78 | US10544126, Example 78 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 70 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9475795 (2016) BindingDB Entry DOI: 10.7270/Q20Z727W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10544126 (2020) BindingDB Entry DOI: 10.7270/Q2MP55NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9475795 (2016) BindingDB Entry DOI: 10.7270/Q20Z727W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347591 (5-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The ability of a compound to block the intracellular release of calcium mediated by PK1 in RBL2H3 cells expressing human PKR1 receptors is determined... | Citation and Details BindingDB Entry DOI: 10.7270/Q2CV4NKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347599 (5-{[3-(4-Chloro-2-ethoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347547 (2-(Azetidin-1-yl)-4-{[3-(4-chloro-2-methylphenyl)p...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347521 (3-Chloro-5-{[3-(4-methoxy-2-methylphenyl)piperidin...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347576 (4-({3-[4-Methoxy-2-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347575 (4-{[3-(4-Chloro-2-ethoxyphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347612 (3-[4-Chloro-2-(trifluoromethyl)phenyl]-1-[(1-methy...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347607 (3-(4-Chloro-2-methylphenyl)-1-[(1-ethyl-1H-pyrazol...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347590 (5-({3-[4-Chloro-2-(trifluoromethyl)phenyl]piperidi...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347584 (5-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347541 (4-{[3-(4-Chlorophenyl)piperidin-1-yl]carbonyl}-N-m...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347596 (5-({3-[4-Methoxy-2-(trifluoromethyl)phenyl]piperid...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347594 (5-{[3-(4-Methoxy-2-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250612 (US10167273, Example 91 | US10544126, Example 91 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The ability of a compound to block the intracellular release of calcium mediated by PK1 in RBL2H3 cells expressing human PKR1 receptors is determined... | Citation and Details BindingDB Entry DOI: 10.7270/Q2CV4NKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250612 (US10167273, Example 91 | US10544126, Example 91 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10544126 (2020) BindingDB Entry DOI: 10.7270/Q2MP55NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250612 (US10167273, Example 91 | US10544126, Example 91 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250612 (US10167273, Example 91 | US10544126, Example 91 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9475795 (2016) BindingDB Entry DOI: 10.7270/Q20Z727W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347610 (4-{[3-(4-Chloro-2-methylphenyl)piperidin-1-yl]carb...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The ability of a compound to block the intracellular release of calcium mediated by PK1 in RBL2H3 cells expressing human PKR1 receptors is determined... | Citation and Details BindingDB Entry DOI: 10.7270/Q2CV4NKN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9475795 (2016) BindingDB Entry DOI: 10.7270/Q20Z727W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM347595 (5-{[3-(4-Methoxy-2-methylphenyl)piperidin-1-yl]car...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US9790201 (2017) BindingDB Entry DOI: 10.7270/Q2377BVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250617 (US10167273, Example 98 | US10544126, Example 96 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10544126 (2020) BindingDB Entry DOI: 10.7270/Q2MP55NK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250611 (US10167273, Example 90 | US10544126, Example 90 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin receptor 1 (Homo sapiens (Human)) | BDBM250595 (US10167273, Example 74 | US10544126, Example 74 | ...) | MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company Limited US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10167273 (2019) BindingDB Entry DOI: 10.7270/Q24F1ST0 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 902 total ) | Next | Last >> |